Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06764381

Study of Viral Respiratory Infections

Study of Viral Respiratory Infections: Retrospective Evaluation of the Circulation of Respiratory Viruses, of Pathogenic-related Clinical Manifestations and of the Clinical Utility of Virological Diagnosis

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Acute viral respiratory infections are a major public health problem, as they cause mortality especially in pediatric patients, over 65 and those with co-morbidities. The most frequently responsible viruses are: Influenza A and B, Respiratory Syncytial Virus, Adenovirus, Parainfluenza Virus, Metapneumovirus, Rhinovirus and SARS-CoV-2. By comparing clinical data and laboratory diagnosis among all categories of patients at greatest risk, it is possible to define the symptoms associated with the pathogen and establish which etiological agents could be able to cause clinical pictures characteristics of a given type of patient. The study will also provide information on the potential role that simultaneously detected pathogens may play in determining the severity of the clinical picture. In addition, the results will allow to deepen the changes in seasonality and spread of different respiratory viruses associated with the COVID-19 pandemic.

Detailed description

The aim of the study is: 1. Calculate the percentage of positive cases during 2018-2023. 2. Association between the viral pathogens detected individually or in packaging in respiratory material and: typology of symptomatology/clinical outcome; typology of clinical signs detectable with objective/instrumental examinations; degree of severity of clinical manifestation. 3. Reduction in the prescription of instrumental investigations (RX/ecoaddome) and reduction in the prescription of empirical antibiotic therapy with amoxicillin or amoxicillin and clavulanic acid in pediatric patients.

Conditions

Timeline

Start date
2025-02-03
Primary completion
2025-03-03
Completion
2026-02-03
First posted
2025-01-08
Last updated
2025-01-08

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06764381. Inclusion in this directory is not an endorsement.